Investors / United States / Pathway Bioventures
Pathway Bioventures
Venture capital · Chicago, IL, United States · North America
Pathway Bioventures is an early-stage life sciences fund that invests in precision therapeutics companies. It co-invests in Seed and Series A rounds within syndicates and helps portfolio companies with subsequent financings and capital-efficient derisking strategies.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechgenetic medicinegene therapycell therapytargeted therapies
Your fit with Pathway Bioventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPathway Bioventures lists 13 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (86%), AI & Machine Learning (7%) and Consumer (7%). 50% of its companies are based in United States. It invests most often alongside LifeLink Ventures, Springboard and Tachyon Ventures.
Counts come from funding rounds that name Pathway Bioventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Pathway Bioventures' whole history. Rounds on record name 1 company; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 72th | 8% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| LifeLink Ventures | 2 |
| Springboard | 2 |
| Tachyon Ventures | 2 |
| +ND Capital | 1 |
| 2048 Ventures | 1 |
| 4BIO Capital | 1 |
| AIN Ventures | 1 |
| ARCH Venture Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1292%
- No longer answers00%
- Points to another company18%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| AI & Machine Learning | 7% | 18% |
| Consumer | 7% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with LifeLink Ventures
Compare Pathway Bioventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Pathway Bioventures| Date | Company | Stage |
|---|---|---|
| 5 May 2026 | Series A |
Round details for Pathway Bioventures
Amounts, full round histories and every co-investor in Pathway Bioventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company invests in life sciences venture capital focused on advanced therapies | Healthcare & Biotech | Portfolio page | ||
| Afference powers communication in the age of AI using neural haptics technology | AI & Machine LearningConsumer | Portfolio page | ||
| Airna is developing novel medicines with the potential to deliver functional cures for patients using RNA editing technology. | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Cytospire Therapeutics develops next generation immune cell engagers, including multispecific antibodies and gamma delta T cell engagers, for cancer therapies. | Healthcare & Biotech | May 2026Series A | Page + round | |
| Cytovale develops a medical device for the diagnosis of sepsis | Healthcare & Biotech | Portfolio page | ||
| Dimension Bio is a biotechnology company pioneering regenerative therapeutics | Healthcare & Biotech | Portfolio page | ||
| Mirecule develops RNA therapies for cancer and muscular dystrophy | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Nionyx is developing next-generation AAV gene therapies for genetic kidney diseases. | Healthcare & Biotech | Portfolio page | ||
| Ochre Bio develops novel medicines for liver disease using human data and AI models | Healthcare & Biotech | Portfolio page | ||
| Scioto Biosciences, Inc is working to meet unmet medical needs of the GI tract and central nervous system | Healthcare & Biotech | Portfolio page | ||
| Simergent develops automated peritoneal dialysis devices for home use. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- pathwaybioventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 5 May 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Pathway Bioventures' profile as data
Pull Pathway Bioventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/pathwaybioventures.com
# also
GET /v1/firms/pathwaybioventures.com/portfolio
GET /v1/firms/pathwaybioventures.com/coinvestors
GET /v1/firms/pathwaybioventures.com/news